APPLICATION
NDA021023
TYPE
NDA
ORIGINAL APPROVAL
2003-10-10
LATEST ACTION
2003-10-10
ROUTE
OPHTHALMIC
DOSAGE FORM
EMULSION
MARKETING STATUS
Prescription
Products
RESTASISPrescription
CYCLOSPORINE 0.05% · EMULSION · OPHTHALMIC
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.